Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01535807 · ClinicalTrials.gov registry record · NA
CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM
A NA study, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01535807 is a NA study that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 44 participants.
The verdict
NCT01535807, a NA study, was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The objective of this study is to identify proteomic inflammatory biomarkers to determine if there are differences in the biomarkers in patients who are treated using the CorMatrix ECM implant to close the pericardium and the patients whose pericardium is left open (the current standard of care).
Interventions
- DEVICE CorMatrix extra cellular matrix (ECM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01535807
The ClinicalTrials.gov registry entry for NCT01535807 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CorMatrix extra cellular matrix (ECM) is the first listed.
NCT01535807 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01535807 about?
NCT01535807 is a clinical study titled "CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM". The objective of this study is to identify proteomic inflammatory biomarkers to determine if there are differences in the biomarkers in patients who are treated using the CorMatrix ECM implant to close the pericardium and the patients whose pericardium is left open (the current standard of care).
What is the current status of trial NCT01535807?
This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2012-01. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01535807?
The interventions under investigation include: CorMatrix extra cellular matrix (ECM) (DEVICE).
Who is sponsoring clinical trial NCT01535807?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.